Documentation Centre

 

 

  of 646 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Nonalcoholic fatty liver disease: An emerging driver of cardiac arrhythmia. Circ Res. 2021;128:1747-1765 November 30, 2021 Nonalcoholic fatty liver disease: An emerging driver of cardiac arrhythmia. Circ Res. 2021;128:1747-1765 Chen Z, Liu J, Zhou F, Li H, Zhang XJ, She ZG, Lu Z, Cai J, Li H Key Publications
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770 November 18, 2021 Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770 Muzurović E, Mikhailidis DP, Mantzoros C Key Publications
Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. Am J Clin Nutr. 2021;113:1265-1274 November 12, 2021 Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. Am J Clin Nutr. 2021;113:1265-1274 Zhang S, Gu Y, Bian S, Lu Z, Zhang Q, Liu L, Meng G, Yao Z, Wu H, Wang Y, Zhang T, Wang X, Sun S, Wang X, Zhou M, Jia Q, Song K, Qi L, Niu K Key Publications
Fighting HFpEF in women: taking aim at belly fat. Eur Heart J. 2021;42:1606-1608 November 02, 2021 Fighting HFpEF in women: taking aim at belly fat. Eur Heart J. 2021;42:1606-1608 Withaar C, Meems LMG, de Boer RA Key Publications
Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J. 2021;42:1595-1605 November 01, 2021 Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J. 2021;42:1595-1605 Sorimachi H, Obokata M, Takahashi N, Reddy YNV, Jain CC, Verbrugge FH, Koepp KE, Khosla S, Jensen MD, Borlaug BA Key Publications
Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. Curr Opin Lipidol. 2021;32:200-206 October 27, 2021 Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. Curr Opin Lipidol. 2021;32:200-206 Santos-Baez LS, Ginsberg HN Key Publications
Nonalcoholic steatohepatitis: Current thinking from the division of hepatology and nutrition at the Food and Drug Administration. Hepatology. 2021;73:2023-2027 October 25, 2021 Nonalcoholic steatohepatitis: Current thinking from the division of hepatology and nutrition at the Food and Drug Administration. Hepatology. 2021;73:2023-2027 Anania FA, Dimick-Santos L, Mehta R, Toerner J, Beitz J Key Publications
NAFLD: Reporting histologic findings in clinical practice. Hepatology. 2021;73:2028-2038 October 25, 2021 NAFLD: Reporting histologic findings in clinical practice. Hepatology. 2021;73:2028-2038 Brunt EM, Kleiner DE, Carpenter DH, Rinella M, Harrison SA, Loomba R, Younossi Z, Neuschwander-Tetri BA, Sanyal AJ; American Association for the Study of Liver Diseases NASH Task Force Key Publications
Life's simple 7 and nonalcoholic fatty liver disease: The Multiethnic Study of Atherosclerosis. Am J Med. 2021;134:519-525 October 19, 2021 Life's simple 7 and nonalcoholic fatty liver disease: The Multiethnic Study of Atherosclerosis. Am J Med. 2021;134:519-525 Oni E, Ogunmoroti O, Allen N, A-Mallah MH, Blankstein R, Martin SS, Zeb I, Cushman M, Joshi PH, Budoff MJ, Blaha MJ, Blumenthal RS, Veledar E, Nasir K Key Publications
Transient elevation of triacylglycerol content in the liver: a fundamental component of the acute response to exercise. J Appl Physiol (1985). 2021;130:1293-1303 October 14, 2021 Transient elevation of triacylglycerol content in the liver: a fundamental component of the acute response to exercise. J Appl Physiol (1985). 2021;130:1293-1303 Henderson GC, Meyer JM Key Publications

  of 646 Next page

Go to page: of